FMI’ Analyst view: “Pharma Packaging’s Frosty Frontier: Maintaining Drug Integrity”

The global temperature-controlled pharma packaging solutions market is projected to rise at 7.8% CAGR and reach a valuation of US$ 7.4 Billion by 2032, up from US$ 4 Billion in 2022.

What Is Driving Market Demand For Temperature Controlled Pharma Packaging Solutions?

“Next-gen Tracking Technology and High Insulation-based Packaging Solutions to Dictate Future Growth Prospects”

Temperature-controlled pharma packaging solutions will continue to see a stronger influence on regulations, considering the nature of the products to be packed and shipped. Moreover, the demand for quality and compliance is growing at a faster rate than innovation. Market players are targeting reinforced composite materials with high insulation-based packaging solutions and stability to set their products apart from the competition.

The greater need for cost-effective solutions for highly temperature-sensitive shipments is likely to direct focus towards lightweight yet high insulation-based packaging solutions. Through next-gen shippers and data management devices, innovative technologies are making their way into the market space, enabling faster, more accurate transparency in the movement of sensitive pharma products.

What Challenges Are Hampering Market Growth?

“Stringent Regulations on Shipment of Temperature-Sensitive Products Restraining Market Growth”

High maintenance and investment cost for temperature-controlled pharmaceutical packaging solutions in the pharmaceutical industry is projected to hinder market growth during the assessment period.

Lack of awareness concerning the benefits of packaging solutions since only a few companies utilize temperature-controlled pharma packaging solutions may hinder market growth. Furthermore, lots of precautions are required to uphold during pharmaceutical product packaging to ascertain their stability and protection such as the container should be dry and clean, etc.

Several stringent government legislations on the use of temperature-sensitive products for producing temperature-controlled packaging solutions are estimated to restrict market growth.

Country-Wise Analysis

Where Does the USA Stand in the Global Market for Temperature-Controlled Pharma Packaging Solutions?

“Rising Usage of Temperature Controlled Medical Products Driving Market Expansion”

The USA temperature-controlled pharma packaging solutions market is expected to grow rapidly because of a huge number of pharmaceutical producers and the increasing use of temperature-controlled medical products.

As a result of the thriving pharmaceutical industry, demand for vaccines, pharmaceuticals, and other temperature-controlled medical products is expected to rise, propelling the market in the USA

What is the Demand Outlook for Temperature Controlled Pharma Packaging Solutions in China?

“Continuous Research and development activities on Thermal Packaging Solutions to Augment Market Growth”

The market in China is expected to witness a faster growth rate because of the growing number of clinical trials. China has seen technological improvements as a result of its growing population and an increasing number of disease outbreaks.

To stay ahead of the competition, several corporations have focused their Research and Development efforts on developing innovative thermal packaging solutions in China.

COVID-19 Impact on Market

The COVID-19 pandemic forced the closure of most manufacturing facilities, The COVID-19 pandemic has forced several businesses to re-establish their respective growth trajectory for approaching years. The market dropped in demand owing to the high influence of COVID-19. This is majorly due to disruption across supply chains.

For shipping vaccines, testing kits, and other important pharmaceuticals, companies invented their packing strategy. Temperature excursions can cause product damage in temperature-controlled packaging. COVID-19 has pushed industry trends in temperature-controlled pharmaceutical packaging solutions. Vaccine manufacturers cooperated with temperature-controlled pharmaceutical packaging vendors to create specialized vaccine shipping products.

Competitive Landscape

Rapid technical innovations and advancements are crucial aspects of the expansion of the industry. Major companies are investing more in research & development to develop more efficient products to set their products apart from the competition.

For instance,

  • Cryoport, Inc., a leading supplier of temperature-controlled supply chain solutions for the life sciences sector, acquired CRYOPDP, a leading provider of advanced temperature-controlled logistics solutions to pharmaceutical, clinical research, and gene & cell therapy markets. The acquisition will provide CRYOPDP noteworthy synergies with Cryoport’s operating entity, Cryoport Systems, with very little overlap in infrastructure and capabilities, from a regional as well as product and service support viewpoint.

These insights are based on a report by Ismail Sutaria Temperature Controlled Pharma Packaging Solutions Market by Future Market Insights.

 

Leave a Comment

Your email address will not be published. Required fields are marked *